Lunit Cancer Screening company information, Employees & Contact Information

Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025 PR Newswire

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine Yahoo Finance

Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program The Korea Herald

AI Meets Precision Medicine: Agilent and Lunit Join Forces to Transform Cancer Diagnostic Testing Stock Titan

Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities PR Newswire

Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025 TNGlobal

Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies PR Newswire

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials The Korea Herald

Lunit Partners with SITC to Launch Exclusive Research Program Featuring Advanced AI Technology for SITC Members PR Newswire

Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis The Korea Herald

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca PR Newswire

Lunit Showcases AI Pathology Advances in Cancer Research from Rare to Common Tumors at AACR 2025 PR Newswire

Lunit AI Enhances Precision in Predicting Outcomes for HER2-Targeted Therapy in Metastatic Colorectal Cancer - new study published in JCO Precision Oncology PR Newswire

Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC PR Newswire

Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network PR Newswire

Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite PR Newswire

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC PR Newswire

Lunit Expands AI Medical Imaging Solutions in East & Southeast Asia: Partners with Chung Shan Medical University and Gleneagles Hospital Singapore PR Newswire

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients PR Newswire

Lunit Secures $150 Million in Capital Increase PR Newswire

AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023 PR Newswire

Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program Imaging Technology News

Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening Imaging Technology News

Lunit Appoints Volpara CEO Teri Thomas as Chief Business Officer of Cancer Screening Group Imaging Technology News

Lunit to Participate in RSNA 2021, Presenting Its New AI Solutions for Digital Breast Tomosynthesis and Chest CT Imaging Technology News

Lunit INSIGHT MMG for Breast Cancer Detection Now CE Certified Imaging Technology News

Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance taiwannews.com.tw

Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries PR Newswire Canada

Lunit Insight Offers Cloud-Based AI Analysis for Chest X-rays Imaging Technology News

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018 Imaging Technology News